Concentrate Aqueous Low-Level Radioactive Waste Into A Disposable Dry Solid With RadAway

What do I do with aqueous low-level radioactive waste? As a radiation safety officer for a small biotechnology company, I found solving that problem to be the most difficult and time-consuming aspect of my job. Faced with limited access to disposal sites, budget-busting costs, and a small waste storage room, I've had to rely completely on decay-in-storage to cope with low-level radioactive waste. Typically, we hold radioactive waste with half-lives less than 90 days for a period equal to 10 ha

Written byMichael Brush
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

What do I do with aqueous low-level radioactive waste?

As a radiation safety officer for a small biotechnology company, I found solving that problem to be the most difficult and time-consuming aspect of my job. Faced with limited access to disposal sites, budget-busting costs, and a small waste storage room, I've had to rely completely on decay-in-storage to cope with low-level radioactive waste. Typically, we hold radioactive waste with half-lives less than 90 days for a period equal to 10 half-lives. This allows the waste to decay to background radiation levels before it is disposed of as normal trash or released into the sanitary sewer. Of course, I thoroughly monitor and inspect the waste before releasing it.

RadAway from Naiad Technologies For an isotope like 32P, 10 half-lives works out to 140 days, or about 5 months. In practice, I've found storing waste for 6 months to a year to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies